{"id":252614,"date":"2024-11-25T22:51:17","date_gmt":"2024-11-25T21:51:17","guid":{"rendered":"https:\/\/r3i.org\/inicio\/"},"modified":"2025-09-26T18:33:31","modified_gmt":"2025-09-26T16:33:31","slug":"inicio","status":"publish","type":"page","link":"https:\/\/r3i.org\/es\/","title":{"rendered":"Inicio"},"content":{"rendered":"

[et_pb_section fb_built=\u00bb1″ admin_label=\u00bbHeader\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bb6234cc3d-b6f8-400b-b428-098eb18d4048″ background_image=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/11\/medical-student-working-with-pad-on-the-conference-sbi-300935057.jpg\u00bb parallax=\u00bbon\u00bb custom_padding=\u00bb8vw||8vw||true|false\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22background_color_gradient_stops%22%93}\u00bb][et_pb_row column_structure=\u00bb2_3,1_3″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb2_3″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbBienvenido a la Iniciativa para la Reducci\u00f3n del Riesgo Residual\u00bb _builder_version=\u00bb4.27.3″ _module_preset=\u00bb85bb96a3-ef78-46ce-aab0-1e7393bf0748″ title_font=\u00bbPoppins||||||||\u00bb title_text_align=\u00bbleft\u00bb title_text_color=\u00bb#FFFFFF\u00bb title_font_size=\u00bb65px\u00bb custom_margin=\u00bb||10px||false|false\u00bb text_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb][\/et_pb_heading][et_pb_heading title=\u00bbSomos una organizaci\u00f3n sin fines de lucro dedicada a abordar el riesgo vascular residual en pacientes que han logrado las metas de tratamiento seg\u00fan los est\u00e1ndares de atenci\u00f3n actuales o aquellos que no han cumplido estas metas.\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbeb37210b-8edd-4727-970a-25cfc5e0f17b\u00bb title_font=\u00bbOpen Sans||||||||\u00bb title_text_color=\u00bb#FFFFFF\u00bb title_font_size=\u00bb21px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_heading][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6Ijc1IiwiZW5hYmxlX2h0bWwiOiJvZmYifX0=@\u00bb button_text=\u00bbM\u00e1s informaci\u00f3n\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bbf68a9626-9603-48cf-bc1e-8b633c7fb19e\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_2,1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb138.8px\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_text_color=\u00bbgcid-primary-color\u00bb header_font_size=\u00bb30px\u00bb custom_margin=\u00bb||1px|||\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_text_color%22%93}\u00bb]<\/p>\n

\u00bfQU\u00c9 ES EL RIESGO RESIDUAL?<\/span><\/h1>\n

[\/et_pb_text][et_pb_video src=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2025\/02\/R3i-definition-M-Hermans.m4v\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_color=\u00bbgcid-primary-color\u00bb header_font_size=\u00bb30px\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_text_color%22%93}\u00bb]<\/p>\n

\u00bfQUE ES LA INICIATIVA?<\/span><\/h1>\n

[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb87px\u00bb custom_margin=\u00bb39px|||||\u00bb custom_margin_tablet=\u00bb39px|||||\u00bb custom_margin_phone=\u00bb0px||||false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb0px||||false|false\u00bb custom_padding_tablet=\u00bb0px||||false|false\u00bb custom_padding_phone=\u00bb0px||||false|false\u00bb custom_padding_last_edited=\u00bbon|desktop\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

Una organizaci\u00f3n acad\u00e9mica, multidisciplinaria y sin fines de lucro que pretende hacer frente al riesgo residual de complicaciones macro y microvasculares en pacientes que no alcanzan sus objetivos de salud a pesar del tratamiento est\u00e1ndar actual.<\/p>\n

La fundaci\u00f3n apoya a los profesionales de la salud manteni\u00e9ndoles informados y capacit\u00e1ndoles para tomar decisiones basadas en pruebas en su pr\u00e1ctica, para salvar potencialmente millones de vidas.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbServices\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb-52px|||||\u00bb locked=\u00bboff\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.27.3″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.3″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_search placeholder=\u00bbBuscar art\u00edculos, publicaciones, v\u00eddeos, eventos…\u00bb admin_label=\u00bbBuscar\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb border_radii=\u00bbon|4px|4px|4px|4px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_search][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_4,1_4,1_4,1_4″ use_custom_gutter=\u00bbon\u00bb gutter_width=\u00bb1″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb190.4px\u00bb custom_margin=\u00bb||30px||false|false\u00bb custom_padding=\u00bb||0px||false|false\u00bb box_shadow_style=\u00bbpreset3″ box_shadow_vertical=\u00bb80px\u00bb box_shadow_blur=\u00bb80px\u00bb box_shadow_spread=\u00bb-80px\u00bb box_shadow_color=\u00bbgcid-7ac71fca-d8d0-448d-9b31-949fbf26d931″ locked=\u00bboff\u00bb global_colors_info=\u00bb{%22gcid-7ac71fca-d8d0-448d-9b31-949fbf26d931%22:%91%22box_shadow_color%22%93}\u00bb][et_pb_column type=\u00bb1_4″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_blurb title=\u00bbPublicaciones\u00bb url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDA3NCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb use_icon=\u00bbon\u00bb font_icon=\u00bb||fa||400″ _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bblink_option_url,url\u00bb _module_preset=\u00bb32c1eeb1-0aad-474b-bacf-64f639536a22″ header_font=\u00bbPoppins||||||||\u00bb header_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb background_color=\u00bbrgba(0,0,0,0.04)\u00bb min_height=\u00bb205px\u00bb custom_padding=\u00bb31px|30px|31px|30px|true|true\u00bb link_option_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDA3NCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22body_quote_text_color%22,%22icon_color%22,%22body_quote_text_color%22,%22icon_color%22,%22body_quote_text_color%22,%22icon_color%22,%22body_quote_text_color%22,%22icon_color%22,%22body_quote_text_color%22,%22icon_color%22%93,%22gcid-secondary-color%22:%91%22background_color__hover%22,%22background_color__hover%22,%22background_color__hover%22,%22background_color__hover%22,%22background_color__hover%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_text_color%22%93}\u00bb background__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_4″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_blurb title=\u00bbFolletos \/ Diapositivas\u00bb url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDExNiIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb use_icon=\u00bbon\u00bb font_icon=\u00bb||divi||400″ _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bburl,link_option_url\u00bb _module_preset=\u00bb32c1eeb1-0aad-474b-bacf-64f639536a22″ header_font=\u00bbPoppins||||||||\u00bb header_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb header_font_size=\u00bb22px\u00bb background_color=\u00bbrgba(0,0,0,0.06)\u00bb min_height=\u00bb173px\u00bb min_height_tablet=\u00bb173px\u00bb min_height_phone=\u00bb173px\u00bb min_height_last_edited=\u00bbon|tablet\u00bb height=\u00bb205px\u00bb custom_padding=\u00bb31px|30px|31px|30px|true|true\u00bb link_option_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDExNiIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22body_quote_text_color%22,%22icon_color%22%93,%22gcid-secondary-color%22:%91%22background_color__hover%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_text_color%22%93}\u00bb background__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_4″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_blurb title=\u00bbWebinars\u00bb url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjEyMCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb use_icon=\u00bbon\u00bb font_icon=\u00bb||divi||400″ _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bburl,link_option_url\u00bb _module_preset=\u00bb32c1eeb1-0aad-474b-bacf-64f639536a22″ header_font=\u00bbPoppins||||||||\u00bb header_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb background_color=\u00bbrgba(0,0,0,0.06)\u00bb min_height=\u00bb204px\u00bb custom_padding=\u00bb31px|30px|31px|30px|true|true\u00bb link_option_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjEyMCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22body_quote_text_color%22,%22icon_color%22%93,%22gcid-secondary-color%22:%91%22background_color__hover%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_text_color%22%93}\u00bb][\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_4″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_blurb title=\u00bbEpisodios\u00bb url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDEwMSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb use_icon=\u00bbon\u00bb font_icon=\u00bb||fa||400″ _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bburl,link_option_url\u00bb _module_preset=\u00bb32c1eeb1-0aad-474b-bacf-64f639536a22″ header_font=\u00bbPoppins||||||||\u00bb header_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb body_font=\u00bbOpen Sans||||||||\u00bb background_color=\u00bbrgba(0,0,0,0.08)\u00bb min_height=\u00bb205px\u00bb custom_padding=\u00bb31px|30px|31px|30px|true|true\u00bb link_option_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDEwMSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22body_quote_text_color%22,%22icon_color%22,%22body_quote_text_color%22%93,%22gcid-secondary-color%22:%91%22background_color__hover%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22header_text_color%22%93}\u00bb][\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_2,1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bblink_option_url\u00bb _module_preset=\u00bbdefault\u00bb text_font=\u00bbOpen Sans||||||||\u00bb text_text_color=\u00bbgcid-primary-color\u00bb header_font=\u00bbPoppins|||on|||||\u00bb header_text_color=\u00bbgcid-primary-color\u00bb header_font_size=\u00bb51px\u00bb background_color=\u00bbrgba(255,255,255,0.6)\u00bb background_image=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2025\/09\/Capture-decran-2025-09-26-182243.png\u00bb background_blend=\u00bboverlay\u00bb min_height=\u00bb568px\u00bb custom_margin=\u00bb||6px|||\u00bb custom_padding=\u00bb209px||44px||false|false\u00bb link_option_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDExNiIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb box_shadow_style=\u00bbpreset2″ global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_text_color%22,%22text_text_color%22%93}\u00bb]<\/p>\n

Biblioteca de folletos<\/span><\/h1>\n

Ofrece conocimientos basados en pruebas sobre terapias innovadoras<\/strong> para gestionar los riesgos vasculares residuales y mejorar los resultados de los pacientes.<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_accordion _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22open_toggle_background_color%22,%22toggle_text_color%22,%22icon_color%22,%22open_toggle_background_color%22,%22toggle_text_color%22,%22icon_color%22,%22open_toggle_background_color%22,%22toggle_text_color%22,%22icon_color%22,%22open_toggle_background_color%22,%22toggle_text_color%22,%22icon_color%22,%22open_toggle_background_color%22,%22toggle_text_color%22,%22icon_color%22%93,%22gcid-2ba1efb6-4031-47e4-a58d-f8150d56f0f2%22:%91%22closed_toggle_background_color%22,%22closed_toggle_background_color%22,%22closed_toggle_background_color%22,%22closed_toggle_background_color%22,%22closed_toggle_background_color%22%93}\u00bb sticky_enabled=\u00bb0″][et_pb_accordion_item title=\u00bbRetinopat\u00eda diab\u00e9tica como afecci\u00f3n microvascular residual\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb open=\u00bbon\u00bb]<\/p>\n

Este folleto, un proyecto de la Iniciativa de Reducci\u00f3n del Riesgo Residual (R3i), est\u00e1 dise\u00f1ado para aumentar significativamente
la conciencia y la comprensi\u00f3n de la retinopat\u00eda diab\u00e9tica (RD) como una condici\u00f3n microvascular residual persistente y a menudo pasada por alto.<\/p>\n

Ver el folleto<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbEsteatohepatitis asociada con la disfunci\u00f3n metab\u00f3lica (MASH)\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb link_option_url=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2025\/04\/MASH-Booklet-v03_HR-ES.pdf\u00bb link_option_url_new_window=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb open=\u00bboff\u00bb]<\/p>\n

La enfermedad de hi\u0301gado graso asociada a la disfuncio\u0301n metabo\u0301lica (MAFLD)<\/span>1<\/span>, antes conocida como enfermedad de hi\u0301gado graso no alcoho\u0301lico (NAFLD)….<\/span><\/p>\n

Ver el folleto<\/span><\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbLa PCSK9 como diana terap\u00e9utica: Perspectivas de los ensayos cl\u00ednicos\u00bb open=\u00bboff\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bblink_option_url\u00bb _module_preset=\u00bbdefault\u00bb link_option_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDI1OSIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″]<\/p>\n

Este folleto\/slidedeck, el segundo de la serie, se centra en las pruebas de los ensayos cl\u00ednicos con terapias dirigidas a la PCSK9.<\/span><\/p>\n

Ver el folleto<\/span><\/p>\n

<\/span><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbLipoprote\u00ednas ricas en triglic\u00e9ridos y enfermedad cardiovascular ateroscler\u00f3tica\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bblink_option_url\u00bb _module_preset=\u00bbdefault\u00bb link_option_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDI3MyIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb open=\u00bboff\u00bb sticky_enabled=\u00bb0″]<\/p>\n

Este folleto proporciona una base cr\u00edtica sobre las lipoprote\u00ednas ricas en triglic\u00e9ridos y su papel en la ASCVD, y concluye con un an\u00e1lisis de los ensayos.<\/span><\/p>\n

Ver el folleto<\/span><\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ custom_padding_last_edited=\u00bboff|desktop\u00bb admin_label=\u00bbFAQ\u00bb _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|||\u00bb custom_padding=\u00bb0px||25px|||\u00bb custom_padding_tablet=\u00bb|0%||\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||25px|||\u00bb use_custom_width=\u00bbon\u00bb width_unit=\u00bboff\u00bb custom_width_percent=\u00bb100%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bb\u00daltimas publicaciones\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbc2f0f3e5-0d4b-4a74-9043-2d265bca952a\u00bb title_font=\u00bbPoppins||||||||\u00bb title_text_color=\u00bbgcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22%93,%22gcid-4907c8d4-9eff-49de-91ce-43a2d3a729cf%22:%91%22title_text_color%22%93}\u00bb][\/et_pb_heading][et_pb_accordion toggle_icon=\u00bb7||divi||400″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb border_radii=\u00bbon|20px|20px|20px|20px\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_accordion_item title=\u00bbLecciones de PROMINENT y perspectivas del permafibrato\u00bb open=\u00bbon\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb link_option_url=\u00bbhttps:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11288121\/pdf\/12933_2024_Article_2305.pdf\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

El resultado neutro del ensayo PROMINENT ha suscitado dudas sobre el futuro del pemafibrato. Este comentario analiza las posibles razones de la falta de beneficio observada en el ensayo. <\/span><\/p>\n

M\u00e1s informaci\u00f3n…<\/span><\/strong><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbModuladores selectivos del receptor alfa activado por el proliferador de peroxisomas (SPPARM\u03b1): \u00bfNuevas oportunidades para reducir el riesgo cardiovascular residual en la enfermedad renal cr\u00f3nica?\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb link_option_url=\u00bbhttps:\/\/link.springer.com\/article\/10.1007\/s11883-020-00860-w\u00bb global_colors_info=\u00bb{}\u00bb open=\u00bboff\u00bb]<\/p>\n

La diferenciaci\u00f3n del pemafibrato de los fibratos actuales pretende abordar necesidades cl\u00ednicas no cubiertas en la ERC. El estudio PROMINENT en curso proporcionar\u00e1 informaci\u00f3n cr\u00edtica sobre la eficacia y seguridad a largo plazo del pemafibrato en pacientes con diabetes mellitus de tipo 2, incluidos los que padecen ERC, y sobre si el perfil modificador de l\u00edpidos favorable se traduce en una reducci\u00f3n del riesgo cardiovascular residual. <\/span><\/p>\n

M\u00e1s informaci\u00f3n…<\/strong><\/span><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbRiesgo vascular residual en la diabetes : \u00bfTendr\u00e1 la clave el concepto SPPARM\u03b1?\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb link_option_url=\u00bbhttps:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1871402119303595?via%3Dihub\u00bb global_colors_info=\u00bb{}\u00bb open=\u00bboff\u00bb]<\/p>\n

Los m\u00e9dicos deben considerar otros objetivos para reducir el riesgo cardiovascular residual en la diabetes. El concepto SPPARM\u03b1 es uno de los principales contendientes, ya que ofrece la oportunidad de actuar en m\u00faltiples dianas relevantes para el riesgo vascular. <\/p>\n

M\u00e1s informaci\u00f3n…<\/strong><\/span><\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDA3NCIsImVuYWJsZV9odG1sIjoib2ZmIn19@\u00bb button_text=\u00bbVea m\u00e1s publicaciones\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb0px||50px||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_2,1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb539.5px\u00bb min_height_tablet=\u00bb539.5px\u00bb min_height_phone=\u00bb890px\u00bb min_height_last_edited=\u00bbon|desktop\u00bb custom_padding=\u00bb|1px||||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.27.3″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bblink_option_url\u00bb _module_preset=\u00bbdefault\u00bb text_font=\u00bbOpen Sans||||||||\u00bb text_text_color=\u00bbgcid-primary-color\u00bb header_font=\u00bbPoppins|||on|||||\u00bb header_text_color=\u00bbgcid-primary-color\u00bb header_font_size=\u00bb51px\u00bb background_color=\u00bbrgba(255,255,255,0.6)\u00bb background_image=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/11\/no-people-shot-of-long-wooden-table-with-six-seats-and-flags-for-each-country-micropho-SBI-351402718.jpg\u00bb background_blend=\u00bboverlay\u00bb width=\u00bb100%\u00bb min_height=\u00bb530px\u00bb min_height_tablet=\u00bb430px\u00bb min_height_phone=\u00bb390px\u00bb min_height_last_edited=\u00bbon|tablet\u00bb custom_margin=\u00bb||23px||false|false\u00bb custom_margin_tablet=\u00bb||23px||false|false\u00bb custom_margin_phone=\u00bb-50px||6px||false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb150px|63px||55px|false|false\u00bb custom_padding_tablet=\u00bb150px|63px||55px|false|false\u00bb custom_padding_phone=\u00bb77px|63px|0px|55px|false|false\u00bb custom_padding_last_edited=\u00bbon|desktop\u00bb link_option_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MDEwMSJ9fQ==@\u00bb box_shadow_style=\u00bbpreset2″ global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_text_color%22,%22text_text_color%22%93}\u00bb]<\/p>\n

Eventos de R3i<\/h1>\n

No se pierda las \u00faltimas noticias de los eventos de R3i y la informaci\u00f3n sobre todos los pr\u00f3ximos eventos.<\/strong><\/p>\n

[\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MjY1MyJ9fQ==@\u00bb button_text=\u00bbDescubre\u00bb button_alignment=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb-143px||||false|false\u00bb custom_margin_tablet=\u00bb-143px||||false|false\u00bb custom_margin_phone=\u00bb-89px||||false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb6px|20px|6px|20px|true|true\u00bb custom_padding_last_edited=\u00bboff|desktop\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.27.3″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bblink_option_url\u00bb _module_preset=\u00bbdefault\u00bb text_font=\u00bbOpen Sans||||||||\u00bb text_text_color=\u00bbgcid-primary-color\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_color=\u00bbgcid-primary-color\u00bb header_font_size=\u00bb51px\u00bb background_color=\u00bbrgba(255,255,255,0.62)\u00bb background_image=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/11\/business-coach-0036.jpg\u00bb background_blend=\u00bboverlay\u00bb width=\u00bb100%\u00bb width_tablet=\u00bb100%\u00bb width_phone=\u00bb100%\u00bb width_last_edited=\u00bbon|phone\u00bb max_width=\u00bb100%\u00bb min_height=\u00bb530px\u00bb min_height_tablet=\u00bb430px\u00bb min_height_phone=\u00bb390px\u00bb min_height_last_edited=\u00bbon|phone\u00bb custom_margin=\u00bb-1px|-189px|2px||false|false\u00bb custom_margin_tablet=\u00bb80px|-189px|58px||false|false\u00bb custom_margin_phone=\u00bb41px|-189px|2px||false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb53px|63px|69px|63px|false|false\u00bb custom_padding_tablet=\u00bb150px|63px|66px|63px|false|false\u00bb custom_padding_phone=\u00bb43px|63px|66px|63px|false|false\u00bb custom_padding_last_edited=\u00bbon|phone\u00bb link_option_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6Ijc5IiwiZW5hYmxlX2h0bWwiOiJvZmYifX0=@\u00bb header_font_size_phone=\u00bb23px\u00bb box_shadow_style=\u00bbpreset2″ global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_text_color%22,%22text_text_color%22%93}\u00bb]<\/p>\n

<\/span>SUSCRIBASE A NUESTRO BOLET\u00cdN<\/h1>\n

Convi\u00e9rtase en miembro para recibir nuestro bolet\u00edn informativo y obtener acceso sin restricciones a nuestros kits de diapositivas para descargar.<\/p>\n

<\/span><\/p>\n

<\/span><\/p>\n

<\/span><\/p>\n

<\/span><\/p>\n

<\/span><\/p>\n

<\/span><\/p>\n

[\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6Ijc5IiwiZW5hYmxlX2h0bWwiOiJvZmYifX0=@\u00bb button_text=\u00bbSuscr\u00edbete\u00bb button_alignment=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb-157px||||false|false\u00bb custom_margin_tablet=\u00bb-147px|||||\u00bb custom_margin_phone=\u00bb-95px||||false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb6px|24px|6px|24px|true|true\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

\u00bfQU\u00c9 ES EL RIESGO RESIDUAL?\u00bfQUE ES LA INICIATIVA?Una organizaci\u00f3n acad\u00e9mica, multidisciplinaria y sin fines de lucro que pretende hacer frente al riesgo residual de complicaciones macro y microvasculares en pacientes que no alcanzan sus objetivos de salud a pesar del tratamiento est\u00e1ndar actual. La fundaci\u00f3n apoya a los profesionales de la salud manteni\u00e9ndoles informados y […]<\/p>\n","protected":false},"author":258497325,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_crdt_document":"","jetpack_post_was_ever_published":true,"footnotes":""},"class_list":["post-252614","page","type-page","status-publish","hentry"],"yoast_head":"\nInicio - R3I<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/r3i.org\/es\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inicio - R3I\" \/>\n<meta property=\"og:description\" content=\"\u00bfQU\u00c9 ES EL RIESGO RESIDUAL?\u00bfQUE ES LA INICIATIVA?Una organizaci\u00f3n acad\u00e9mica, multidisciplinaria y sin fines de lucro que pretende hacer frente al riesgo residual de complicaciones macro y microvasculares en pacientes que no alcanzan sus objetivos de salud a pesar del tratamiento est\u00e1ndar actual. La fundaci\u00f3n apoya a los profesionales de la salud manteni\u00e9ndoles informados y […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/r3i.org\/es\/\" \/>\n<meta property=\"og:site_name\" content=\"R3I\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-26T16:33:31+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"16 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/\",\"url\":\"https:\\\/\\\/r3i.org\\\/es\\\/\",\"name\":\"Inicio - R3I\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#website\"},\"datePublished\":\"2024-11-25T21:51:17+00:00\",\"dateModified\":\"2025-09-26T16:33:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/r3i.org\\\/es\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/r3i.org\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inicio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/r3i.org\\\/es\\\/\",\"name\":\"R3I\",\"description\":\"Residual Risk Reduction Initiative\",\"publisher\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/r3i.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#organization\",\"name\":\"R3I\",\"url\":\"https:\\\/\\\/r3i.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/r3i.org\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/r3i.org\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1\",\"width\":1601,\"height\":834,\"caption\":\"R3I\"},\"image\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inicio - R3I","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/r3i.org\/es\/","og_locale":"es_ES","og_type":"article","og_title":"Inicio - R3I","og_description":"\u00bfQU\u00c9 ES EL RIESGO RESIDUAL?\u00bfQUE ES LA INICIATIVA?Una organizaci\u00f3n acad\u00e9mica, multidisciplinaria y sin fines de lucro que pretende hacer frente al riesgo residual de complicaciones macro y microvasculares en pacientes que no alcanzan sus objetivos de salud a pesar del tratamiento est\u00e1ndar actual. La fundaci\u00f3n apoya a los profesionales de la salud manteni\u00e9ndoles informados y […]","og_url":"https:\/\/r3i.org\/es\/","og_site_name":"R3I","article_modified_time":"2025-09-26T16:33:31+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"16 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/r3i.org\/es\/","url":"https:\/\/r3i.org\/es\/","name":"Inicio - R3I","isPartOf":{"@id":"https:\/\/r3i.org\/es\/#website"},"datePublished":"2024-11-25T21:51:17+00:00","dateModified":"2025-09-26T16:33:31+00:00","breadcrumb":{"@id":"https:\/\/r3i.org\/es\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/r3i.org\/es\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/r3i.org\/es\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/r3i.org\/es\/"},{"@type":"ListItem","position":2,"name":"Inicio"}]},{"@type":"WebSite","@id":"https:\/\/r3i.org\/es\/#website","url":"https:\/\/r3i.org\/es\/","name":"R3I","description":"Residual Risk Reduction Initiative","publisher":{"@id":"https:\/\/r3i.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/r3i.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/r3i.org\/es\/#organization","name":"R3I","url":"https:\/\/r3i.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/r3i.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/r3i.org\/wp-content\/uploads\/2024\/11\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1","contentUrl":"https:\/\/i0.wp.com\/r3i.org\/wp-content\/uploads\/2024\/11\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1","width":1601,"height":834,"caption":"R3I"},"image":{"@id":"https:\/\/r3i.org\/es\/#\/schema\/logo\/image\/"}}]}},"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/Pgbfv2-13Iq","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages\/252614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/users\/258497325"}],"replies":[{"embeddable":true,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/comments?post=252614"}],"version-history":[{"count":20,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages\/252614\/revisions"}],"predecessor-version":[{"id":256053,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages\/252614\/revisions\/256053"}],"wp:attachment":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/media?parent=252614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}